Biotech | August 08, 2022
Biocon Sdn. Bhd. enters Malaysia Book of Records
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Subscribe To Our Newsletter & Stay Updated
